4-hydroxytamoxifen does not deteriorate cardiac function in cardiomyocyte-specific MerCreMer transgenic miceAndré Heinen(Düsseldorf University Hospital), Axel Gödecke(Düsseldorf University Hospital)Basic Research in CardiologyFebruary 5, 202110.1007/s00395-020-00841-9Cited by 10SaveCiteExport RISWatch citationsRelated PapersSystematic Analysis Reveals Elongation Factor 2 and α-Enolase as Novel Interaction Partners of AKT2|PLoS ONE|2013|15